Artificial Organ & Bionics Market - Global Forecast 2026-2032

The Artificial Organ & Bionics Market is projected to reach USD 30.19 Billion in 2026. It is expected to continue growing at a CAGR of 9.43%, reaching USD 52.11 Billion by 2032.

Artificial organs and bionics are moving from life-sustaining interventions to digitally enabled medical technology platforms that restore mobility, sensory function, circulation, renal filtration, and metabolic control. Demand is structurally supported by the persistent gap between transplant need and donor-organ availability, aging populations, rising diabetes and cardiovascular disease prevalence, and improved survivorship after trauma, stroke, limb loss, and chronic illness.

Verified public-health indicators reinforce the need for artificial organs, implantable bionics, neuroprosthetics, and assistive technologies. The U.S. Organ Procurement and Transplantation Network reports that more than 100,000 people are on the national transplant waiting list, with kidneys representing the largest share. The World Health Organization reports that more than 2.5 billion people need at least one assistive product, with this need expected to rise as populations age and noncommunicable diseases increase. These realities are accelerating clinical and policy attention on artificial kidneys, ventricular assist devices, cochlear implants, neuroprosthetics, myoelectric limbs, retinal implants, bionic hands, and smart exoskeletons.

Transformative Shifts in the Artificial Organ & Bionics Landscape

The artificial organ and bionics landscape is being reshaped by the convergence of advanced biomaterials, robotics, implantable electronics, 3D printing, regenerative medicine, wearable sensors, and connected care. Devices that were once primarily mechanical are increasingly sensor-rich, software-controlled, and designed for remote monitoring, predictive maintenance, personalized therapy adjustment, and improved patient-device interaction.

Regulatory expectations are also evolving across major healthcare systems. The U.S. Food and Drug Administration, European notified bodies operating under the EU Medical Device Regulation, and national health technology assessment bodies are placing stronger emphasis on clinical evidence, cybersecurity, usability engineering, post-market surveillance, and real-world performance. This is shifting competitive advantage toward developers that can combine clinical outcomes, patient experience, reimbursement evidence, manufacturing quality, and lifecycle data integrity.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler across artificial organs and bionic systems. In prosthetics, machine learning can improve intent recognition from electromyography signals, helping bionic limbs respond more naturally to user movement. In cardiac assist devices and implantable monitoring ecosystems, AI-enabled analytics can support earlier identification of pump performance changes, arrhythmia risk, and patient deterioration signals when integrated with clinically validated workflows.

The cumulative impact of artificial intelligence is operational as well as clinical. AI supports patient selection, digital twin modeling, design optimization, imaging analysis, additive-manufacturing quality control, rehabilitation personalization, and post-market vigilance. However, successful deployment depends on validated datasets, explainability, bias mitigation, cybersecurity, human factors engineering, and alignment with medical-device software regulations, including FDA guidance on software functions and internationally recognized quality-management practices.

Key Regional Insights

Asia-Pacific is one of the most dynamic demand centers for artificial organs and bionics due to large patient populations, high diabetes burden, expanding hospital infrastructure, and domestic medtech manufacturing strength across China, Japan, South Korea, India, Australia, and Southeast Asia. Japan and South Korea show strong uptake potential in advanced prosthetics, cochlear implants, surgical robotics, and rehabilitation technologies, while India and ASEAN healthcare systems are increasingly focused on affordability, local production, and broader access to renal replacement technologies, assistive devices, and limb rehabilitation.

North America remains a global leader in high-acuity artificial organs, neuroprosthetics, ventricular assist devices, cochlear implants, and implantable bionics, supported by mature clinical trial networks, FDA regulatory pathways, venture financing, specialty care capacity, and established reimbursement channels. Europe benefits from strong clinical research, rehabilitation systems, organ-transplant infrastructure, and EU regulatory harmonization, although Medical Device Regulation transition requirements have increased evidence, documentation, and compliance expectations. Latin America shows rising need for renal, cardiac, auditory, and prosthetic solutions, with Brazil and Mexico acting as important access hubs. The Middle East is advancing through specialized hospitals, transplant programs, rehabilitation investment, and medical tourism strategies, while Africa presents substantial unmet need, with adoption closely tied to public procurement, workforce development, affordability, infrastructure availability, and nonprofit or donor-supported access models.

Key Group Insights

ASEAN markets are gaining relevance as healthcare capacity expands and governments prioritize medical-device access, yet affordability, reimbursement coverage, procurement efficiency, and specialist availability remain decisive for artificial organ and bionics adoption. GCC countries are investing in advanced hospitals, rehabilitation, transplant-related care, and specialty surgical capacity, creating opportunities for premium artificial organ, implantable bionics, cochlear implant, and prosthetic technologies supported by public health spending and medical tourism strategies.

The European Union is influential through the EU Medical Device Regulation, cross-border research funding, coordinated health data initiatives, and gradual health technology assessment convergence. BRICS countries combine large chronic disease burdens with growing domestic manufacturing ambitions, especially in China, India, and Brazil, while Russia and South Africa add distinct regional clinical and access dynamics. G7 markets remain central to premium innovation, reimbursement evidence, clinical validation, and regulatory precedent setting. NATO members’ defense rehabilitation ecosystems continue to support advanced prosthetics, powered exoskeletons, osseointegration research, and trauma-related bionic innovation, particularly for injured service members and complex rehabilitation pathways.

Key Country Insights

The United States leads in commercialization pathways, venture funding, clinical trials, transplant-adjacent innovation, advanced prosthetics, neurotechnology, and high-acuity artificial organ adoption, while Canada emphasizes publicly funded care pathways, health technology assessment, and evidence-based adoption. Mexico and Brazil are important Latin American markets, supported by large populations, growing specialty care networks, and rising chronic disease needs, although reimbursement variability and out-of-pocket exposure can limit access to high-end bionic systems.

The United Kingdom, Germany, France, Italy, and Spain anchor European demand through national health systems, rehabilitation networks, specialist surgical capacity, and structured procurement processes; Germany is particularly strong in engineering-led prosthetics, orthotics, and medtech manufacturing. Russia maintains scientific and clinical capability in selected areas, but procurement constraints, technology-transfer limits, and supply-chain friction influence adoption. China is scaling domestic medtech production, hospital modernization, cochlear implantation, and advanced rehabilitation technologies, while India presents large unmet need and cost-sensitive adoption opportunities across renal replacement, prosthetics, and assistive devices. Japan and South Korea remain advanced robotics, implant, and rehabilitation technology markets with aging-population demand, and Australia benefits from strong cochlear implant expertise, rehabilitation services, clinical research infrastructure, and public-private care pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated differentiation rather than feature proliferation. The strongest artificial organ and bionics strategies will link device performance to measurable outcomes such as mobility improvement, auditory or visual function gains, dialysis independence goals, hospitalization reduction, quality-of-life improvement, device longevity, lower complication rates, and reduced total cost of care.

Manufacturers and technology developers should build evidence packages early, including real-world data plans, cybersecurity documentation, health-economic models, usability validation, and patient-reported outcomes. Partnerships with transplant centers, rehabilitation clinics, dialysis providers, payers, veterans’ health systems, academic hospitals, and public procurement bodies can shorten adoption cycles. Companies should also design for serviceability, inclusive ergonomics, interoperability, training efficiency, and regional affordability to address both premium innovation markets and access-oriented healthcare systems.

Research Methodology

This executive summary is developed using secondary research from verifiable public and institutional sources, including organ transplant registries, health agencies, regulatory bodies, peer-reviewed literature, medical-device guidance documents, clinical trial registries, and publicly available healthcare infrastructure information. Sources commonly referenced in validation include the World Health Organization, U.S. Food and Drug Administration, Organ Procurement and Transplantation Network, Eurotransplant, national health services, international disease-burden databases, and recognized standards or regulatory guidance for medical devices and software-enabled systems.

The methodology triangulates demand drivers, disease prevalence, transplant access indicators, technology adoption signals, regulatory developments, reimbursement considerations, manufacturing trends, clinical evidence requirements, and regional healthcare infrastructure. Insights are structured to support strategic decision-making for manufacturers, suppliers, investors, providers, policymakers, rehabilitation networks, and procurement stakeholders across the artificial organ and bionics ecosystem.

Conclusion

The artificial organ and bionics market is entering a more data-driven, patient-centered, and evidence-intensive phase. Structural demand is reinforced by transplant shortages, chronic disease burden, aging demographics, limb loss, sensory impairment, trauma survivorship, and the global need for assistive technologies.

Competitive leadership will depend on integrated capabilities across advanced materials, robotics, implantable electronics, AI-enabled monitoring, clinical validation, regulatory excellence, cybersecurity, and scalable manufacturing. Organizations that align innovation with affordability, measurable outcomes, serviceability, and regional access needs will be best positioned to strengthen adoption across healthcare systems.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Organ & Bionics Market, by Product Type

7.1. Introduction
7.2. Artificial Organs
7.2.1. Kidney
7.2.2. Heart
7.2.2.1. Total Artificial Heart
7.2.2.2. Ventricular Assist Devices
7.2.2.3. Artificial Heart Valves
7.2.3. Lungs
7.2.4. Liver
7.2.5. Pancreas
7.3. Artificial Bionics
7.3.1. Vision Bionics
7.3.2. Ear Bionics
7.3.3. Orthopedic Bionics
7.3.4. Cardiac Bionics
7.3.5. Exoskeletons

8. Artificial Organ & Bionics Market, by Technology

8.1. Introduction
8.2. Mechanical
8.3. Electronic

9. Artificial Organ & Bionics Market, by Fixation Type

9.1. Introduction
9.2. Implantable Devices
9.3. Wearable Devices

10. Artificial Organ & Bionics Market, by Material Type

10.1. Introduction
10.2. Metals
10.2.1. Titanium
10.2.2. Stainless Steel
10.3. Polymers
10.4. Ceramics
10.5. Biomaterials
10.5.1. Collagen-based
10.5.2. Hydrogel-based

11. Artificial Organ & Bionics Market, by Application

11.1. Introduction
11.2. Organ Failure Treatment
11.3. Sensory Restoration
11.3.1. Hearing Restoration
11.3.2. Vision Restoration
11.4. Mobility Restoration
11.5. Neurological Disorders
11.6. Cardiovascular Disorders
11.7. Orthopedic Disorders

12. Artificial Organ & Bionics Market, by End User

12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Homecare
12.4. Hospitals
12.5. Specialty Clinics

13. Artificial Organ & Bionics Market, by Distribution Channel

13.1. Introduction
13.2. Online
13.3. Offline

14. Artificial Organ & Bionics Market, by Region

14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa

15. Artificial Organ & Bionics Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Artificial Organ & Bionics Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. Competitive Landscape

17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025

18. Company Profiles

18.1. Abbott Laboratories
18.2. Abiomed Inc.
18.3. ALung Technologies Inc.
18.4. Asahi Kasei Medical Co Ltd
18.5. AWAK Technologies Pte Ltd
18.6. Baxter International Inc.
18.7. Berlin Heart GmbH
18.8. BiVACOR Pty Ltd
18.9. Boston Scientific Corporation
18.10. CARMAT SA
18.11. Cochlear Limited
18.12. Cyberdyne Inc.
18.13. Edwards Lifesciences Corporation
18.14. Ekso Bionics Holdings Inc.
18.15. Fresenius Medical Care AG
18.16. Getinge AB
18.17. Jarvik Heart Inc.
18.18. Medtronic plc
18.19. Ottobock SE & Co KGaA
18.20. Second Sight Medical Products Inc.
18.21. Sonova Holding AG
18.22. SynCardia Systems LLC
18.23. Terumo Corporation
18.24. Zimmer Biomet Holdings Inc.

List of Figures

FIGURE 1. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL KIDNEY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL KIDNEY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL KIDNEY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HEART MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HEART MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HEART MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LUNGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LUNGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL LUNGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL LIVER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL LIVER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL LIVER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PANCREAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PANCREAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PANCREAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL BIONICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL VISION BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL VISION BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL VISION BIONICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL EAR BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL EAR BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL EAR BIONICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ORTHOPEDIC BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ORTHOPEDIC BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ORTHOPEDIC BIONICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CARDIAC BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CARDIAC BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CARDIAC BIONICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL EXOSKELETONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL EXOSKELETONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL EXOSKELETONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MECHANICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MECHANICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MECHANICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ELECTRONIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ELECTRONIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ELECTRONIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL METALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL METALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CERAMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CERAMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CERAMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HYDROGEL-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HYDROGEL-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HYDROGEL-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ORGAN FAILURE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ORGAN FAILURE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ORGAN FAILURE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SENSORY RESTORATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SENSORY RESTORATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SENSORY RESTORATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HEARING RESTORATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HEARING RESTORATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HEARING RESTORATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL VISION RESTORATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL VISION RESTORATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL VISION RESTORATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL MOBILITY RESTORATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL MOBILITY RESTORATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL MOBILITY RESTORATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 176. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 179. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 180. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 181. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 182. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 183. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 184. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 185. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 186. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 188. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 205. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 206. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 207. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 208. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 209. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 211. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 212. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 213. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 214. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 215. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 216. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 218. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 222. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 223. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 224. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 225. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 226. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 227. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 228. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 229. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 231. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 234. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 236. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 237. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 238. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 239. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 240. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 241. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 242. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 243. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 245. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 262. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 263. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 264. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 265. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 266. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 268. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 269. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 270. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 271. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 273. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 275. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 278. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 279. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 280. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 282. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 283. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 284. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 285. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 287. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 289. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 290. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 292. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 293. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 294. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 296. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 297. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 298. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 299. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 301. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 303. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 312. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 313. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 314. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 316. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 318. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 319. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 320. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 321. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 322. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 323. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 324. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 325. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 326. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 327. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 328. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 329. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 330. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 332. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 334. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 335. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 336. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 337. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 338. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2017-2032 (USD MILLION)
TABLE 339. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 340. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2017-2032 (USD MILLION)
TABLE 341. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2017-2032 (USD MILLION)
TABLE 342. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 343. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2017-2032 (USD MILLION)
TABLE 344. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 346. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 347. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 348. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2017-2032 (USD MILLION)
TABLE 349. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2017-2032 (USD MILLION)
TABLE 350. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2017-2032 (USD MILLION)
TABLE 351. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2017-

Companies Mentioned

Abbott Laboratories
Abiomed Inc.
ALung Technologies Inc.
Asahi Kasei Medical Co Ltd
AWAK Technologies Pte Ltd
Baxter International Inc.
Berlin Heart GmbH
BiVACOR Pty Ltd
Boston Scientific Corporation
CARMAT SA
Cochlear Limited
Cyberdyne Inc.
Edwards Lifesciences Corporation
Ekso Bionics Holdings Inc.
Fresenius Medical Care AG
Getinge AB
Jarvik Heart Inc.
Medtronic plc
Ottobock SE & Co KGaA
Second Sight Medical Products Inc.
Sonova Holding AG
SynCardia Systems LLC
Terumo Corporation
Zimmer Biomet Holdings Inc.

Table Information

Report Attribute	Details
No. of Pages	186
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 30.19 Billion
Forecasted Market Value ( USD ) by 2032	$ 52.11 Billion
Compound Annual Growth Rate	9.4%
Regions Covered	Global
No. of Companies Mentioned	24

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Artificial Organ & Bionics Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights

Key Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Artificial Organs and Bionics - Global Strategic Business Report

Artificial Organs Market - Global Forecast 2026-2032

Artificial Organ and Bionics Market Outlook 2025-2034: Market Share, and Growth Analysis

Medical Bionic Implant/Artificial Organs Market Outlook 2025-2034: Market Share, and Growth Analysis

Artificial Vital Organs and Medical Bionics Market Report by Product Type, Application, and Region 2026-2034